Clinical Trial Update: Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of 10XB-101 in adults with bilateral flank adiposity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subcutaneous Fat Disorder

Drugs mentioned

• 10XB-101 (10XB-101)

Snippet

Sponsor: 10xBio, LLC | Conditions: Subcutaneous Fat Disorder | Phase 2 | Status: COMPLETED